+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analgesics Market Size, Share & Trends Analysis Report By Drug Type (Opioid, Non-opioid, Compound Medication), By Route Of Administration, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 150 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 5846790
Description Jump to:
The global analgesics market size is expected to reach USD 61.39 billion by 2030, according to this report. Furthermore, the industry is expected to expand at a CAGR of 6.02% during the forecast period. The growth is aided by the rising prevalence of chronic disorders and the surge in the geriatric population globally. Moreover, ongoing regulatory approvals of innovative analgesics and increasing R&D activities are other key factors contributing to market growth. For instance, in October 2021, the U.S. FDA approved a combination pill containing tramadol and celecoxib for acute pain management in adult patients.

The increasing incidences of chronic and acute pain conditions are expected to offer lucrative growth opportunities in the market for analgesics. For instance, in April 2021, according to the International Association for the Study of Pain, over 50.2 million adults in the U.S. reported pain every day, with the most common types being knee, back, and foot pain. Some of the common analgesics prescribed for these conditions are fentanyl, codeine, and NSAIDs such as acetaminophen, celecoxib, and others.

In addition, the surge in the global geriatric population is expected to increase the prevalence of chronic diseases, which is expected to drive the market growth for analgesics. America’s Health Rankings Senior Report 2021 states that according to the U.S. Census Bureau, more than 54 million adults aged 65 and above reside in the U.S. The geriatric population is more prone to chronic conditions such as cancer, cardiovascular disorders, musculoskeletal diseases, and associated pain with these diseases. Moreover, according to the NIH, the prevalence of chronic neuropathic pain in the geriatric population is 10-52%.

The advancements in the designing and development of novel drugs to boost patient compliance and improve the safety of existing therapeutics are driving the market growth forward. For instance, analgesics such as Naproxen, Voltaren-XR (diclofenac), and tramadol, among others, are available in extended-release tablet forms. Volini Maxx spray by Sun Pharmaceutical Industries Ltd. and Bayer’s AleveX spray are examples of targeted spray technology for better spray control without mess and drip. Increasing adoption of these products is expected to drive market growth in musculoskeletal applications.

The increasing demand for combination analgesics and opioid analgesics due to their high efficacy is motivating market players to develop novel & effective pain management drugs. For instance, in 2022, there were eight new CBD and THC molecules in phase 3 clinical trials in the U.S. for difficult-to-treat pain conditions.

Furthermore, various developments such as partnerships, new product launches, and collaborations undertaken by leading players are other factors contributing to the market growth. For instance, in August 2021, Alkem Laboratories announced the launch of famotidine and ibuprofen tablets for the management of osteoarthritis and rheumatoid arthritis symptoms in the U.S.

In addition, in December 2020, Sandoz, a Novartis division, announced the immediate availability of acetaminophen generic injection in the U.S. This injection is used for the management of mild to moderate pain in adult as well as pediatric patients. Moreover, the growing approval of combination drugs to reduce the side effects of analgesics is further expected to increase the market growth for analgesics in the coming years.

Analgesics Market Report Highlights

  • The non-opioid drug type segment held the largest market share in 2022, owing to lesser side effects than opioid analgesics and a lower chance of developing drug dependency
  • Based on the route of administration, the oral segment dominated the market for analgesics due to the lack of requirement of any special apparatus for drug administration and high patient compliance for the oral route
  • The surgical & trauma application segment was the leading revenue contributor during the base year, which is attributed to the significantly large number of surgeries performed globally every year
  • The online pharmacies segment is anticipated to exhibit the fastest growth rate, owing to the increasing adoption of telemedicine and the emergence of several e-commerce sites to sell medical products
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period, due to rising investments in the region by major manufacturers and extensive unmet medical needs


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.1.1 Segment Definitions
1.1.1.1 Drug type segment
1.1.1.2 Application segment
1.1.1.3 Route of administration segment
1.1.1.4 Distribution channel segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.6.5 Details Of Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
2.2 Segment Snapshot
2.3 Competitive Landscape
Chapter 3 Global Analgesics Market Variables, Trends, & Scope
3.1 Analgesics Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration And Growth Prospect Mapping
3.3 Market Driver Analysis
3.3.1 Increasing Prevalence Of Chronic Diseases
3.3.2 Surge In Geriatric Population
3.3.3 Rising Demand For Otc Painkillers
3.4 Market Restraint Analysis
3.4.1 Side Effects Associated With Long Term Use Of Analgesics
3.4.2 Rising Abusive Use Of Opoid Analgesics
3.5 Porter’s Five Forces Analysis
3.6 Swot Analysis
3.7 Covid-19 Impact Analysis
Chapter 4 Analgesics Market - Segment Analysis, By Drug Type, 2018 - 2030 (USD Million)
4.1 Global Analgesics Market: Drug Type Movement Analysis
4.2 Opioid
4.2.1 Opioid Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Non-Opioid
4.3.1 Non-Opioid Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 Compound Medication
4.4.1 Compound Medication Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 Analgesics Market - Segment Analysis, By Route Of Administration, 2018 - 2030 (USD Million)
5.1 Global Analgesics Market: Route Of Administration Movement Analysis
5.2 Oral
5.2.1 Oral Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Parenteral
5.3.1 Parenteral Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Transdermal
5.4.1 Transdermal Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Others
5.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 Analgesics Market- Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
6.1 Analgesics Market: Distribution Channel Movement Analysis
6.2 Hospital Pharmacies
6.2.1 Hospital Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Retail Pharmacies
6.3.1 Retail Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Online Pharmacies
6.4.1 Online Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 Analgesics Market- Segment Analysis, By Application, 2018 - 2030 (USD Million)
7.1 Analgesics Market: Application Movement Analysis
7.2. Musculoskeletal
7.2.1 Musculoskeletal Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Surgical And Trauma
7.3.1 Surgical & Trauma Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Cancer
7.4.1 Cancer Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Neuropathic
7.5.1 Neuropathic Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Migraine
7.6.1 Migraine Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.7 Obstetrical
7.7.1 Obstetrical Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.8 Fibromyalgia
7.8.1 Fibromyalgia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.9 Pain Due To Burns
7.9.1 Pain Due To Burns Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.10 Dental/Facial
7.10.1 Dental/Facial Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.11 Pediatric
7.11.1 Pediatric Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.12 Others
7.12.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 Analgesics Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)
8.1 Analgesics Market: Regional Movement Analysis
8.2 North America
8.2.1 SWOT Analysis
8.2.1.1 North America Analgesics Market, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 Key country dynamics
8.2.2.2 Competitive scenario
8.2.2.3 U.S. analgesics market, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Key country dynamics
8.2.3.2 Competitive scenario
8.2.3.3 Canada analgesics market, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Swot Analysis
8.3.1.1 Europe Analgesics Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 UK
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.3 UK Analgesics Market, 2018 - 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 Germany Analgesics Market, 2018 - 2030 (USD Million)
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 France Analgesics Market, 2018 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Italy Analgesics Market, 2018 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Competitive Scenario
8.3.6.3 Spain Analgesics Market, 2018 - 2030 (USD Million)
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Competitive Scenario
8.3.7.3 Denmark Analgesics Market, 2018 - 2030 (USD Million)
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Competitive Scenario
8.3.8.3 Sweden Analgesics Market, 2018 - 2030 (USD Million)
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Competitive Scenario
8.3.9.3 Norway Analgesics Market, 2018 - 2030 (USD Million)
8.3.10 Rest Of Europe
8.3.10.1 Key Country Dynamics
8.3.10.2 Competitive Scenario
8.3.10.3 Rest Of Europe Analgesics Market, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Swot Analysis
8.4.1.1 Asia Pacific Analgesics Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Japan Analgesics Market, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 China Analgesics Market, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 India Analgesics Market, 2018 - 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Australia Analgesics Market, 2018 - 2030 (USD Million)
8.4.6 South Korea
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 South Korea Analgesics Market, 2018 - 2030 (USD Million)
8.4.7 Thailand
8.4.7.1 Key Country Dynamics
8.4.7.2 Competitive Scenario
8.4.7.3 Thailand Analgesics Market, 2018 - 2030 (USD Million)
8.4.8 Rest Of Asia Pacific
8.4.8.1 Key Country Dynamics
8.4.8.2 Competitive Scenario
8.4.8.3 Rest Of Asia Pacific Analgesics Market, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Swot Analysis
8.5.1.1 Latin America Analgesics Market, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Brazil Analgesics Market, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Mexico Analgesics Market, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Argentina Analgesics Market, 2018 - 2030 (USD Million)
8.5.5 Rest Of Latin America
8.5.5.1 Key Country Dynamics
8.5.5.2 Competitive Scenario
8.5.5.3 Rest Of Latin America Analgesics Market, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Swot Analysis
8.6.1.1 Mea Analgesics Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 Competitive Scenario
8.6.2.3 South Africa Analgesics Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Competitive Scenario
8.6.3.3 Saudi Arabia Analgesics Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 Key Country Dynamics
8.6.4.2 Competitive Scenario
8.6.4.3 UAE Analgesics Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.5 Kuwait
8.6.5.1 Key Country Dynamics
8.6.5.2 Competitive scenario
8.6.5.3 Kuwait analgesics market estimates and forecast, 2018 - 2030 (USD Million)
8.6.6 Rest of MEA
8.6.6.1 Key country dynamics
8.6.6.2 Competitive scenario
8.6.6.3 Rest of MEA analgesics estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Profiles
9.1.1 Bayer AG
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic Initiatives
9.1.2 Endo International plc
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic Initiatives
9.1.3 Assertio Holdings, Inc.
9.1.3.1 Company overview
9.1.3.2 Financial performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic Initiatives
9.1.4 Janssen Global Services, LLC
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic Initiatives
9.1.5 GSK plc
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Product benchmarking
9.1.5.4 Strategic Initiatives
9.1.6 AbbVie Inc
9.1.6.1 Company overview
9.1.6.2 Financial performance
9.1.6.3 Product benchmarking
9.1.6.4 Strategic Initiatives
9.1.7 Novartis AG
9.1.7.1 Company overview
9.1.7.2 Financial performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 Viatris Inc.
9.1.8.1 Company overview
9.1.8.2 Financial performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.9 Teva Pharmaceutical Industries Ltd.
9.1.9.1 Company overview
9.1.9.2 Financial performance
9.1.9.3 Product benchmarking
9.1.9.4 Strategic initiatives
9.2 Strategy Mapping
9.2.1 Expansions
9.2.2 Acquisitions
9.2.3 Collaborations
9.2.4 Product/service launches
9.2.5 Partnerships
9.2.6 Others
9.3 Company Market Share Analysis, 2022
9.4 Company Position Analysis, 2022
9.5 Market Participant Categorization
List of Tables
Table 1: List of Secondary Sources
Table 2: List of Abbreviations
Table 3: Leading Market Players Anticipated to Witness Highest Growth
Table 4: Global Analgesics Market, By Region, 2018-2030 (USD Million)
Table 5: Global Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 6: Global Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 7: Global Analgesics Market, By Application, 2018-2030 (USD Million)
Table 8: Global Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 9: North America Analgesics Market, By Country, 2018-2030 (USD Million)
Table 10: North America Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 11: North America Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 12: North America Analgesics Market, By Application, 2018-2030 (USD Million)
Table 13: North America Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 14: U.S. Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 15: U.S. Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 16: U.S. Analgesics Market, By Application, 2018-2030 (USD Million)
Table 17: U.S. Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 18: Canada Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 19: Canada Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 20: Canada Analgesics Market, By Application, 2018-2030 (USD Million)
Table 21: Canada Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 22: Europe Analgesics Market, By Country, 2018-2030 (USD Million)
Table 23: Europe Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 24: Europe Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 25: Europe Analgesics Market, By Application, 2018-2030 (USD Million)
Table 26: Europe Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 27: Germany Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 28: Germany Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 29: Germany Analgesics Market, By Application, 2018-2030 (USD Million)
Table 30: Germany Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 31: UK Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 32: UK Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 33: UK Analgesics Market, By Application, 2018-2030 (USD Million)
Table 34: UK Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 35: France Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 36: France Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 37: France Analgesics Market, By Application, 2018-2030 (USD Million)
Table 38: France Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 39: Spain Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 40: Spain Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 41: Spain Analgesics Market, By Application, 2018-2030 (USD Million)
Table 42: Spain Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 43: Italy Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 44: Italy Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 45: Italy Analgesics Market, By Application, 2018-2030 (USD Million)
Table 46: Italy Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 47: Denmark Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 48: Denmark Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 49: Denmark Analgesics Market, By Application, 2018-2030 (USD Million)
Table 50: Denmark Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 51: Sweden Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 52: Sweden Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 53: Sweden Analgesics Market, By Application, 2018-2030 (USD Million)
Table 54: Sweden Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 55: Norway Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 56: Norway Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 57: Norway Analgesics Market, By Application, 2018-2030 (USD Million)
Table 58: Norway Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 59: Asia Pacific Analgesics Market, By Country, 2018-2030 (USD Million)
Table 60: Asia Pacific Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 61: Asia Pacific Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 62: Asia Pacific Analgesics Market, By Application, 2018-2030 (USD Million)
Table 63: Asia Pacific Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 64: Japan Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 65: Japan Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 66: Japan Analgesics Market, By Application, 2018-2030 (USD Million)
Table 67: Japan Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 68: China Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 69: China Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 70: China Analgesics Market, By Application, 2018-2030 (USD Million)
Table 71: China Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 72: India Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 73: India Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 74: India Analgesics Market, By Application, 2018-2030 (USD Million)
Table 75: India Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 76: South Korea Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 77: South Korea Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 78: South Korea Analgesics Market, By Application, 2018-2030 (USD Million)
Table 79: South Korea Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 80: Australia Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 81: Australia Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 82: Australia Analgesics Market, By Application, 2018-2030 (USD Million)
Table 83: Australia Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 84: Thailand Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 85: Thailand Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 86: Thailand Analgesics Market, By Application, 2018-2030 (USD Million)
Table 87: Thailand Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 88: Latin America Analgesics Market, By Country, 2018-2030 (USD Million)
Table 89: Latin America Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 90: Latin America Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 91: Latin America Analgesics Market, By Application, 2018-2030 (USD Million)
Table 92: Latin America Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 93: Brazil Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 94: Brazil Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 95: Brazil Analgesics Market, By Application, 2018-2030 (USD Million)
Table 96: Brazil Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 97: Argentina Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 98: Argentina Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 99: Argentina Analgesics Market, By Application, 2018-2030 (USD Million)
Table 100: Argentina Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 101: Mexico Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 102: Mexico Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 103: Mexico Analgesics Market, By Application, 2018-2030 (USD Million)
Table 104: Mexico Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 105: Middle East and Africa Analgesics Market, By Country, 2018-2030 (USD Million)
Table 106: Middle East and Africa Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 107: Middle East and Africa Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 108: Middle East and Africa Analgesics Market, By Application, 2018-2030 (USD Million)
Table 109: Middle East and Africa Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 110: South Africa Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 111: South Africa Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 112: South Africa Analgesics Market, By Application, 2018-2030 (USD Million)
Table 113: South Africa Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 114: Saudi Arabia Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 115: Saudi Arabia Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 116: Saudi Arabia Analgesics Market, By Application, 2018-2030 (USD Million)
Table 117: Saudi Arabia Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 118: UAE Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 119: UAE Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 120: UAE Analgesics Market, By Application, 2018-2030 (USD Million)
Table 121: UAE Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 122: Kuwait Analgesics Market, By Drug Type, 2018-2030 (USD Million)
Table 123: Kuwait Analgesics Market, By Route of Administration, 2018-2030 (USD Million)
Table 124: Kuwait Analgesics Market, By Application, 2018-2030 (USD Million)
Table 125: Kuwait Analgesics Market, By Distribution Channel, 2018-2030 (USD Million)
List of Figures
Fig. 1: Analgesics market segmentation
Fig. 2: Market research process
Fig. 3: Information procurement
Fig. 4: Primary research pattern
Fig. 5: Market research approaches
Fig. 6: Value-chain-based sizing & forecasting
Fig. 7: QFD modeling for market share assessment
Fig. 8: Market formulation & validation
Fig. 9: Market outlook (2022)
Fig. 10: Strategy framework
Fig. 11: Market driver relevance analysis (Current & future impact)
Fig. 12: Market restraint relevance analysis (Current & future impact)
Fig. 13: Penetration & growth prospect mapping
Fig. 14: Porter’s five forces analysis
Fig. 15: PESTLE analysis
Fig. 16: Analgesics market: Drug type movement analysis
Fig. 17: Analgesics market: Drug type segment dashboard
Fig. 18: Analgesics market Drug type outlook: Key takeaways
Fig. 19: Opioids market estimates and forecast, 2018-2030 (USD Million)
Fig. 20: Non-opioids market estimates and forecast, 2018-2030 (USD Million)
Fig. 21: Compound medication market estimates and forecast, 2018-2030 (USD Million)
Fig. 22: Analgesics market: Route of administration movement analysis
Fig. 23: Analgesics market: Route of administration segment dashboard
Fig. 24: Analgesics market Route of administration outlook: Key takeaways
Fig. 25: Oral market estimates and forecast, 2018-2030 (USD Million)
Fig. 26: Parenteral market estimates and forecast, 2018-2030 (USD Million)
Fig. 27: Transdermal market estimates and forecast, 2018-2030 (USD Million)
Fig. 28: Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 29: Analgesics market: Application movement analysis
Fig. 30: Analgesics market: Application segment dashboard
Fig. 31: Analgesics market Application outlook: Key takeaways
Fig. 32: Musculoskeletal market estimates and forecast, 2018-2030 (USD Million)
Fig. 33: Surgical & trauma market estimates and forecast, 2018-2030 (USD Million)
Fig. 34: Cancer market estimates and forecast, 2018-2030 (USD Million)
Fig. 35: Neuropathic market estimates and forecast, 2018-2030 (USD Million)
Fig. 36: Migraine market estimates and forecast, 2018-2030 (USD Million)
Fig. 37: Obstetrical market estimates and forecast, 2018-2030 (USD Million)
Fig. 38: Fibromyalgia market estimates and forecast, 2018-2030 (USD Million)
Fig. 39: Pain due to burns market estimates and forecast, 2018-2030 (USD Million)
Fig. 40: Dental/facial market estimates and forecast, 2018-2030 (USD Million)
Fig. 41: Pediatric market estimates and forecast, 2018-2030 (USD Million)
Fig. 42: Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 43: Analgesics market: Distribution channel movement analysis
Fig. 44: Analgesics market: Distribution channel segment dashboard
Fig. 45: Analgesics market Distribution channel outlook: Key takeaways
Fig. 46: Hospital pharmacies market estimates and forecast, 2018-2030 (USD Million)
Fig. 47: Retail pharmacies market estimates and forecast, 2018-2030 (USD Million)
Fig. 48: Online pharmacies market estimates and forecast, 2018-2030 (USD Million)
Fig. 49: Regional outlook, 2022 & 2030
Fig. 50: Regional market dashboard
Fig. 51: Regional market place: Key takeaways
Fig. 52: North America, SWOT
Fig. 53: Europe, SWOT
Fig. 54: Asia Pacific, SWOT
Fig. 55: Latin America, SWOT
Fig. 56: Middle East and Africa, SWOT
Fig. 57: North America
Fig. 58: North America analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 59: U.S.
Fig. 60: U.S. analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 61: Canada
Fig. 62: Canada analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 63: Europe
Fig. 64: Europe analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 65: UK
Fig. 66: UK analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 67: Germany
Fig. 68: Germany analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 69: Spain
Fig. 70: Spain analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 71: France
Fig. 72: France analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 73: Italy
Fig. 74: Italy analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 75: Denmark
Fig. 76: Denmark analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 77: Sweden
Fig. 78: Sweden analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 79: Norway
Fig. 80: Norway analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 81: Asia Pacific
Fig. 82: Asia Pacific analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 83: Japan
Fig. 84: Japan analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 85: China
Fig. 86: China analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 87: India
Fig. 88: India analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 89: South Korea
Fig. 90: South Korea analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 91: Australia
Fig. 92: Australia analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 93: Thailand
Fig. 94: Thailand analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 95: Latin America
Fig. 96: Latin America analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 97: Brazil
Fig. 98: Brazil analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 99: Mexico
Fig. 100: Mexico analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 101: Argentina
Fig. 102: Argentina analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 103: Middle East and Africa
Fig. 104: MEA analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 105: South Africa
Fig. 106: South Africa analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 107: Saudi Arabia
Fig. 108: Saudi Arabia analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 109: UAE
Fig. 110: UAE analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 111: Kuwait
Fig. 112: Kuwait analgesics market estimates and forecast, 2018-2030 (USD Million)
Fig. 113: Ansoff Matrix
Fig. 114: Heat map analysis
Fig. 115: Market differentiators

Companies Mentioned

  • Bayer AG
  • Endo International plc
  • Assertio Holdings, Inc.
  • Janssen Global Services, LLC
  • GSK plc
  • AbbVie Inc
  • Novartis AG
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 38.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 61.39 Billion
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Global Analgesics Market by Drug Type (Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, Salicylates), Type (Non-Opioids, Opioids), Route of Administration, Distribution - Forecast 2024-2030 - Product Image

Global Analgesics Market by Drug Type (Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, Salicylates), Type (Non-Opioids, Opioids), Route of Administration, Distribution - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
North America Analgesics Market Report by Type, Drug Class, Route of Administration, Pain Type, Application, and Country 2024-2032 - Product Image

North America Analgesics Market Report by Type, Drug Class, Route of Administration, Pain Type, Application, and Country 2024-2032

  • Report
  • 123 Pages
  • North America
From
Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain Relief, Anesthesia), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain Relief, Anesthesia), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 120 Pages
  • Global
From
Global Analgesics Market: Analysis By Drug Class (Opioids and Non-Opioids), By Route of Administration (Oral, Topical, Intravenous, Transdermal and Rectal), By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028 - Product Image

Global Analgesics Market: Analysis By Drug Class (Opioids and Non-Opioids), By Route of Administration (Oral, Topical, Intravenous, Transdermal and Rectal), By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028

  • Report
  • 159 Pages
  • Global
From
Non-Opioid Analgesic Patch Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Non-Opioid Analgesic Patch Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 128 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.